Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Subramanian

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2023
Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA AnalysisNam Q Bui, Neda Nemat-Gorgani, Ajay Subramanian, et al.
Cancer Research|January 14, 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy ResponseErik S Blomain, Shaghayegh Soudi, Ziwei Wang, et al.
JCI Insight|August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomasChang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcomaChang Su, Collin L Kent, Matthew Pierpoint, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Nature Cancer|March 1, 2024
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapyAjay Subramanian, Neda Nemat-Gorgani, Timothy J Ellis-Caleo, et al.
Nature Communications|September 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphomaAjay Subramanian, Shengqin Su, Jamie Flerlage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2023
Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA AnalysisNam Q Bui, Neda Nemat-Gorgani, Ajay Subramanian, et al.
Cancer Research|January 14, 2025
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy ResponseErik S Blomain, Shaghayegh Soudi, Ziwei Wang, et al.
JCI Insight|August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomasChang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcomaChang Su, Collin L Kent, Matthew Pierpoint, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Nature Cancer|March 1, 2024
Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapyAjay Subramanian, Neda Nemat-Gorgani, Timothy J Ellis-Caleo, et al.
Nature Communications|September 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphomaAjay Subramanian, Shengqin Su, Jamie Flerlage, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2026
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcome in SarcomaEvan Rosenbaum, Fiona Ehrich, Mohammad Yosofvand, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 2